Cargando…
Aspirin vs Clopidogrel: Antiplatelet Agent of Choice for Those With Recent Bleeding or at Risk for Gastrointestinal Bleed
Antiplatelet agents are used worldwide mainly for primary and secondary prevention of cardiovascular events on a long-term basis for mortality benefit. Gastrointestinal bleeding is a well-known adverse effect. Various factors are to be considered while choosing antiplatelet agents to prevent the ris...
Autores principales: | Gosavi, Siddharth, Krishnan, Gokul, Acharya, Raviraja V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199733/ https://www.ncbi.nlm.nih.gov/pubmed/37213942 http://dx.doi.org/10.7759/cureus.37890 |
Ejemplares similares
-
Management of Upper Gastrointestinal Bleeding by an Internist
por: Saleem, Saad, et al.
Publicado: (2018) -
Bleeding tendency in dual antiplatelet therapy with aspirin/clopidogrel: rescue of the template bleeding time in a single-center prospective study
por: Altman, Raul, et al.
Publicado: (2012) -
No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
por: Laredo, Viviana, et al.
Publicado: (2020) -
A Case of Disseminated Melioidosis With Cerebritis
por: Bhat, Vaibhav, et al.
Publicado: (2023) -
Analysis of Gastrointestinal Prophylaxis in Patients Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel
por: Morneau, Kathleen M., et al.
Publicado: (2014)